Islet-specific T-cell responses and proinflammatory monocytes define subtypes of autoantibody-negative ketosis-prone diabetes

Diabetes Care

Volumn 36, Issue 12, 2013, Pages 4098-4103

  Brooks Worrell, Barbara M ^a,b   Iyer, Dinakar ^c   Coraza, Ivonne ^c   Hampe, Christiane S ^a   Nalini, Ramaswami ^c,d   Ozer, Kerem ^c   Narla, Radhika ^a,b   Palmer, Jerry P ^a,b   Balasubramanyam, Ashok ^c,d  

^a UNIVERSITY OF WASHINGTON   (United States)

^b VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d BEN TAUB GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD16 ANTIGEN; AUTOANTIBODY; BIOLOGICAL MARKER; DNA; HLA DR ANTIGEN;

ALLELE; ARTICLE; AUTOIMMUNITY; CELL FUNCTION; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIABETIC KETOACIDOSIS; FEMALE; GENOTYPE; HLA SYSTEM; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNE RESPONSE; INSULIN DEPENDENT DIABETES MELLITUS; KETOSIS PRONE DIABETES; LONGITUDINAL STUDY; MALE; MONOCYTE; PANCREAS ISLET BETA CELL; PHENOTYPE; T LYMPHOCYTE; ADOLESCENT; ADULT; AGED; BLOOD; CHILD; FOLLOW UP; GENETICS; IMMUNOBLOTTING; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AUTOANTIBODIES; BIOMARKERS; CHILD; DIABETES MELLITUS, TYPE 1; DIABETIC KETOACIDOSIS; DNA; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HLA-DR ANTIGENS; HUMANS; IMMUNOBLOTTING; INSULIN-SECRETING CELLS; MALE; MIDDLE AGED; MONOCYTES; PHENOTYPE; REAL-TIME POLYMERASE CHAIN REACTION; T-LYMPHOCYTES; YOUNG ADULT;

EID: 84891862471     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-2328     Document Type: Article

References (22)

1. Maldonado M, Hampe CS, Gaur LK, et al. Ketosis-prone diabetes: dissection of a heterogeneous syndrome using an immunogenetic and beta-cell functional classification, prospective analysis, and clinical outcomes. J Clin Endocrinol Metab 2003;88:5090-5098
2. Nalini R, Gaur LK, Maldonado MR, et al. HLA class II alleles specify phenotypes of ketosis-prone diabetes. Diabetes Care 2008;31:1195-1200
3. Balasubramanyam A, Garza G, Rodriguez L, et al. Accuracy and predictive value of classification schemes for ketosis-prone diabetes. Diabetes Care 2006;29:2575-2579
4. Nalini R, Ozer K, Maldonado M, et al. Presence or absence of a known diabetic ketoacidosis precipitant defines distinct syndromes of "A-b+" ketosis-prone diabetes based on long-termb-cell function, human leukocyte antigen class II alleles, and sex predilection. Metabolism 2010; 59:1448-1455
5. Goel A, Chiu H, Felton J, Palmer JP, Brooks-Worrell B. T-cell responses to islet antigens improves detection of autoimmune diabetes and identifies patients with more severe β-cell lesions in phenotypic type 2 diabetes. Diabetes 2007;56:2110-2115
6. Brooks-Worrell BM, Reichow JL, Goel A, Ismail H, Palmer JP. Identification of autoantibody-negative autoimmune type 2 diabetic patients. Diabetes Care 2011; 34:168-173
7. Ziegler-Heitbrock L. The CD14+ CD16+ blood monocytes: their role in infection and inflammation. J Leukoc Biol 2007;81: 584-592
8. Hampe CS, Nalini R, Maldonado MR, et al. Association of amino-terminalspecific antiglutamate decarboxylase (GAD65) autoantibodies with beta-cell functional reserve and a milder clinical phenotype in patients with GAD65 antibodies and ketosis-prone diabetes mellitus. J Clin Endocrinol Metab 2007; 92:462-467
9. Vaziri-Sani F, Oak S, Radtke J, et al. ZnT8 autoantibody titers in type 1 diabetes patients decline rapidly after clinical onset. Autoimmunity 2010;43:598-606
10. Seyfert-Margolis V, Gisler TD, Asare AL, et al. Analysis of T-cell assays to measure autoimmune responses in subjects with type 1 diabetes: results of a blinded controlled study. Diabetes 2006;55:2588-2594
11. Herold KC, Brooks-Worrell B, Palmer J, et al.; Type 1 Diabetes Trial Net Research Group. Validity and reproducibility of measurement of islet autoreactivity by T-cell assays in subjects with early type 1 diabetes. Diabetes 2009;58:2588-2595
12. Bingley PJ, Bonifacio E, Mueller PW. Diabetes Antibody Standardization Program: first assay proficiency evaluation. Diabetes 2003;52:1128-1136
13. Brooks-Worrell BM, Starkebaum GA, Greenbaum C, Palmer JP. Peripheral blood mononuclear cells of insulindependent diabetic patients respond to multiple islet cell proteins. J Immunol 1996;157:5668-5674
14. Brooks-Worrell B, Gersuk VH, Greenbaum C, Palmer JP. Intermolecular antigen spreading occurs during the preclinical period of human type 1 diabetes. J Immunol 2001;166:5265-5270
15. Brooks-Worrell B, Warsen A, Palmer JP. Improved T cell assay for identification of type 1 diabetes patients. J Immunol Methods 2009;344:79-83
16. Gersuk VH, Nepom GT. A real-time PCR approach for rapid high resolution subtyping of HLA-DRB1*04. J Immunol Methods 2006;317:64-70
17. Gersuk VH, Nepom GT. A real-time polymerase chain reaction assay for the rapid identification of the autoimmune disease-associated allele HLADQB1*0602, Tissue Antigens 2009;73: 335-340
18. Balasubramanyam A, Nalini R, Hampe CS, Maldonado M. Syndromes of ketosisprone diabetes mellitus. Endocr Rev 2008;29:292-302
19. Brooks-Worrell BM, Juneja R, Minokadeh A, Greenbaum CJ, Palmer JP. Cellular immune responses to human islet proteins in antibody-positive type 2 diabetic patients. Diabetes 1999;48:983-988
20. Ghanim H, Aljada A, Hofmeyer D, Syed T, Mohanty P, Dandona P. Circulating mononuclear cells in the obese are in a proinflammatory state. Circulation 2004; 110:1564-1571
21. + ketosis-prone diabetes. Diabetes 2013;62:912-922
22. Haaland WC, Scaduto DI, Maldonado MR, et al. A-β-subtype of ketosis-prone diabetes is not predominantly a monogenic diabetic syndrome. Diabetes Care 2009;32:873-877